Code Cart Crisis: Anatomy Of An Emergency Drug Shortage
Executive Summary
How FDA, health care providers, and Pfizer and other drug makers are responding to a shortage of emergency medicines from the fragile, overstressed US sterile injectables sector.
You may also be interested in...
To Lower Drug Prices, Look At Generic Industry Health Rather Than FDA, Woodcock Says
US FDA can encourage and increase competition, but cannot force generic companies to enter markets deemed unprofitable, CDER director says.
To Lower Drug Prices, Look At Generic Industry Health Rather Than FDA, Woodcock Says
US FDA can encourage and increase competition, but cannot force generic companies to enter markets deemed unprofitable, CDER director says.
Could US Solve Drug Shortages With 'Heightened' M&A Scrutiny?
FDA's inter-agency drug shortage task force wants comments on whether new shortage prevention and mitigation policies should include closer examination of mergers and acquisitions that could create drug shortages.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: